Yifan Xinfu Pharmaceutical Co Ltd (002019) - Total Liabilities
Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has total liabilities worth CN¥4.08 Billion CNY (≈ $597.66 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Yifan Xinfu Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Yifan Xinfu Pharmaceutical Co Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Yifan Xinfu Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Yifan Xinfu Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baoding Heavy Industry Co Ltd
SHE:002552
|
China | CN¥2.99 Billion |
|
Amara Raja Batteries Limited
NSE:ARE&M
|
India | Rs31.10 Billion |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
USA | $14.80 Billion |
|
SL Science Holding Limited Ordinary Shares
NASDAQ:SLBT
|
USA | $533.28K |
|
Mitra Adiperkasa Tbk
JK:MAPI
|
Indonesia | Rp14.63 Trillion |
|
Toyou Feiji Electronics Co Ltd
SHE:300302
|
China | CN¥763.67 Million |
|
CSC Financial Co. Ltd
F:CS0
|
Germany | €557.67 Billion |
|
Zhejiang Weixing Industrial Development Co Ltd
SHE:002003
|
China | CN¥2.28 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Yifan Xinfu Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yifan Xinfu Pharmaceutical Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yifan Xinfu Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yifan Xinfu Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual total liabilities of Yifan Xinfu Pharmaceutical Co Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.13 Billion ≈ $604.94 Million |
+7.13% |
| 2024-12-31 | CN¥3.86 Billion ≈ $564.69 Million |
+18.93% |
| 2023-12-31 | CN¥3.24 Billion ≈ $474.80 Million |
-4.50% |
| 2022-12-31 | CN¥3.40 Billion ≈ $497.15 Million |
+0.20% |
| 2021-12-31 | CN¥3.39 Billion ≈ $496.16 Million |
+13.44% |
| 2020-12-31 | CN¥2.99 Billion ≈ $437.38 Million |
-7.87% |
| 2019-12-31 | CN¥3.24 Billion ≈ $474.71 Million |
+12.36% |
| 2018-12-31 | CN¥2.89 Billion ≈ $422.49 Million |
+45.42% |
| 2017-12-31 | CN¥1.99 Billion ≈ $290.54 Million |
-35.60% |
| 2016-12-31 | CN¥3.08 Billion ≈ $451.13 Million |
+85.03% |
| 2015-12-31 | CN¥1.67 Billion ≈ $243.81 Million |
+110.58% |
| 2014-12-31 | CN¥791.21 Million ≈ $115.78 Million |
+174.54% |
| 2013-12-31 | CN¥288.20 Million ≈ $42.17 Million |
-50.37% |
| 2012-12-31 | CN¥580.73 Million ≈ $84.98 Million |
-16.65% |
| 2011-12-31 | CN¥696.73 Million ≈ $101.95 Million |
+39.97% |
| 2010-12-31 | CN¥497.79 Million ≈ $72.84 Million |
+118.99% |
| 2009-12-31 | CN¥227.31 Million ≈ $33.26 Million |
-20.35% |
| 2008-12-31 | CN¥285.39 Million ≈ $41.76 Million |
-15.03% |
| 2007-12-31 | CN¥335.87 Million ≈ $49.15 Million |
+25.36% |
| 2006-12-31 | CN¥267.92 Million ≈ $39.21 Million |
+36.68% |
| 2005-12-31 | CN¥196.02 Million ≈ $28.68 Million |
+302.32% |
| 2004-12-31 | CN¥48.72 Million ≈ $7.13 Million |
-53.48% |
| 2003-12-31 | CN¥104.73 Million ≈ $15.32 Million |
+99.37% |
| 2002-12-31 | CN¥52.53 Million ≈ $7.69 Million |
+49.85% |
| 2001-12-31 | CN¥35.05 Million ≈ $5.13 Million |
-- |
About Yifan Xinfu Pharmaceutical Co Ltd
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more